CompoZr® Oncology Disease Model Cell Lines by Merck

Manufacturer Merck
We have applied CompoZr Zinc Finger Nuclease technology to create an unparalleled range of genetically modified mammalian cell lines for use in areas, such as target validation, drug discovery and drug development.


CompoZr® Oncology Disease Model Cell Lines by Merck product image
CompoZr® Oncology Disease Model Cell Lines
Request Pricing

Merck

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews